CSIMarket
 


F star Therapeutics Inc   (FSTX)
Other Ticker:  
 

F Star Therapeutics Inc 's Leverage Ratio

FSTX's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -7.79%, in III Quarter 2022 ,Leverage Ratio deteriorated to 0.46 is above the company's typical Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2022, 317 other companies have achieved lower Leverage Ratio than F Star Therapeutics Inc in the III Quarter 2022. While Leverage Ratio total ranking has deteriorated compared to the second quarter 2022 from 1003 to 1332 .

Explain Leverage Ratio?
Who are FSTX Customers?
What are FSTX´s Total Liabilities?


FSTX Leverage Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change -36.79 % -27.63 % 153.05 % 125.28 % 391.85 %
Y / Y Total Liabilities Change 9.3 % 12.27 % 45.49 % 22.52 % 165.89 %
Leverage Ratio MRQ 0.46 0.39 0.29 0.26 0.26
FSTX's Total Ranking # 1332 # 1003 # 833 # 458 # 815
Seq. Equity Change -20.52 % -18.75 % -8.98 % 7.53 % -9.01 %
Seq. Total Liabilities Change -7.79 % 9.74 % 1.54 % 6.38 % -5.29 %



Leverage Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 318
Healthcare Sector # 576
Overall Market # 1332


Leverage Ratio Statistics
High Average Low
1.02 0.44 0.19
(Mar 31 2017)   (Jun 30 2019)




Financial Statements
F Star Therapeutics Inc 's Equity $ 57 Millions Visit FSTX's Balance sheet
F Star Therapeutics Inc 's Total Liabilities $ 26 Millions Visit FSTX's Balance sheet
Source of FSTX's Sales Visit FSTX's Sales by Geography


Cumulative F Star Therapeutics Inc 's Leverage Ratio

FSTX's Leverage Ratio for the trailling 12 Months

FSTX Leverage Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth -36.79 % -27.63 % 153.05 % 125.28 % 391.85 %
Y / Y Total Liabilities TTM Growth 9.3 % 12.27 % 45.49 % 22.52 % 165.89 %
Leverage Ratio TTM 0.33 0.3 0.27 0.29 0.33
Total Ranking TTM # 46 # 741 # 703 # 543 # 7
Seq. Equity TTM Growth -20.52 % -18.75 % -8.98 % 7.53 % -9.01 %
Seq. Total Liabilities TTM Growth -7.79 % 9.74 % 1.54 % 6.38 % -5.29 %


On the trailing twelve months basis Despite of the repayements of liabilities of -7.79% in the trailing twelve months ending in III Quarter 2022, Leverage Ratio improved to 0.33, above F Star Therapeutics Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 8, during the past 12 months, other companies have achieved lower Leverage Ratio than F Star Therapeutics Inc . While Leverage Ratio total ranking has improved so far to 46, from total ranking in previous 12 month period at 741.

Explain Leverage Ratio?
Who are FSTX Customers?
What are FSTX´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 16
Within the Market # 46


trailing twelve months Leverage Ratio Statistics
High Average Low
0.44 0.18 0.05
(Jun 30 2020)   (Jun 30 2021)




Companies with similar Leverage Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Leverage RatioSep 30 2022 MRQ Total LiabilitiesSep 30 2022 MRQ Equity
Pacira Biosciences inc   1.25 $ 964.242  Millions$ 770.123  Millions
Capricor Therapeutics inc   1.25 $ 19.244  Millions$ 15.426  Millions
Perrigo Company Plc  1.20 $ 5,528.500  Millions$ 4,602.700  Millions
Unicycive Therapeutics Inc   1.20 $ 5.551  Millions$ 4.626  Millions
2seventy Bio Inc   1.19 $ 385.564  Millions$ 323.180  Millions
Catalent Inc   1.17 $ 5,505.000  Millions$ 4,700.000  Millions
Ardelyx Inc   1.16 $ 77.811  Millions$ 66.861  Millions
Johnson and Johnson  1.16 $ 86,504.000  Millions$ 74,599.000  Millions
Merck and Co Inc   1.16 $ 51,546.000  Millions$ 44,524.000  Millions
Axsome Therapeutics Inc   1.15 $ 181.596  Millions$ 157.361  Millions
Mirum Pharmaceuticals Inc   1.15 $ 195.050  Millions$ 169.297  Millions
Arvinas Inc   1.15 $ 713.300  Millions$ 621.500  Millions
Marinus Pharmaceuticals Inc   1.14 $ 93.338  Millions$ 82.004  Millions
Sonoma Pharmaceuticals Inc   1.13 $ 7.941  Millions$ 7.021  Millions
Sigilon Therapeutics Inc   1.13 $ 50.208  Millions$ 44.410  Millions
Lifevantage Corp  1.12 $ 35.710  Millions$ 31.890  Millions
Geron Corp  1.11 $ 120.608  Millions$ 108.172  Millions
Royalty Pharma Plc  1.11 $ 11,520.505  Millions$ 10,416.403  Millions
Pfizer Inc  1.11 $ 102,718.000  Millions$ 92,891.000  Millions
Cartesian Therapeutics Inc   1.10 $ 93.358  Millions$ 84.907  Millions
Alaunos Therapeutics Inc   1.10 $ 35.231  Millions$ 32.113  Millions
Elanco Animal Health Inc  1.08 $ 7,287.000  Millions$ 6,745.000  Millions
Can fite Biopharma Ltd   1.07 $ 4.797  Millions$ 4.472  Millions
Sellas Life Sciences Group Inc   1.06 $ 13.404  Millions$ 12.597  Millions
Tg Therapeutics Inc   1.06 $ 106.828  Millions$ 100.481  Millions
Oncorus Inc   1.05 $ 84.369  Millions$ 79.996  Millions
Accustem Sciences Inc   1.03 $ 0.825  Millions$ 0.798  Millions
Immunogen inc   1.02 $ 180.792  Millions$ 178.007  Millions
Otonomy Inc   1.02 $ 21.719  Millions$ 21.397  Millions
Aptevo Therapeutics Inc   1.01 $ 15.933  Millions$ 15.762  Millions

Date modified: 2022-11-13T01:14:33+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com